The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects
- 18 January 2017
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (4) , 579-587
Abstract
The association between ALOX5AP SG13S114 polymorphism and ischemic stroke (IS) susceptibility has extensively been investigated, especially in white populations; however, the results were inconclusive. Here, we perform a meta-analysis to clarify the effect of SG13S114 variant on the IS risk in Europeans. The Web of Science, PubMed, EMBASE, and Medline were searched up to August 1st, 2016. Data were extracted and the odd ratios (ORs) and 95% confidence intervals (CIs) were calculated by a fixed-effects or random-effects model. In total, 8 case control studies involved 8062 subjects were finally included in this meta-analysis. We observed a significantly decreased IS risk in persons carrying an A allele at the SG13S114 polymorphism compared with those with a T allele (A vs T, OR = 0.856, 95% CI = 0.797–0.919, p < 0.001). In addition, the results of sensitivity and cumulative meta-analysis indicated the robustness of our results. In addition, the publication bias was not detected using the funnel plot and Egger’s tests. In summary, the present meta-analysis suggested that the A allele at the ALOX5AP SG13S114 polymorphism is a protective factor for the IS in the Europeans. In addition, further studies with large sample size are needed to validate the association, as well as in other ethnic groups.Keywords
Funding Information
- The National Natural Science Foundation of China (No. 81171147)
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. JX10231801)
This publication has 41 references indexed in Scilit:
- No association of ALOX5AP polymorphisms with risk of MRI-defined brain infarctsNeurobiology of Aging, 2012
- Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic strokeAtherosclerosis, 2009
- Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in SardiniansEuropean Journal of Human Genetics, 2009
- Genetic Variation in Members of the Leukotriene Biosynthesis Pathway Confer an Increased Risk of Ischemic StrokeStroke, 2008
- Association of ALOX5AP with ischemic stroke: a population-based case-control studyHuman Genetics, 2007
- Genetic Variants of Arachidonate 5-Lipoxygenase–Activating Protein, and Risk of Incident Myocardial Infarction and Ischemic StrokeStroke, 2006
- Association between phosphodiesterase 4D gene and ischaemic strokeJournal of Neurology, Neurosurgery & Psychiatry, 2006
- ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke PatientsStroke, 2005
- Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish PopulationThe American Journal of Human Genetics, 2005
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986